Valuation: DVx Inc.

Market Cap 11.86B 75.27M 66.23M 62.64M 56.82M 107M 7.23B 107M 745M 289M 3.69B 283M 277M P/E 2024
61.4x
P/E 2025 23.9x
Enterprise Value 6.81B 43.23M 38.04M 35.98M 32.64M 61.29M 4.15B 61.65M 428M 166M 2.12B 162M 159M EV / Sales 2024
0.05x
EV / Sales 2025 0.08x
Free-Float
27.82%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Director of Finance/CFO 52 01/06/2024
President 49 26/06/2026
Corporate Officer/Principal 52 -
Director TitleAgeSince
Chairman 61 26/06/2026
Director/Board Member 65 01/06/2020
Director/Board Member - 01/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 63.33M
-0.44%+1.36%+30.17%+17.38% 9.63B
-1.27%-0.61%+4.98%+6.38% 1.43B
-7.26%-8.60%-39.07% - 1.24B
-1.06%-1.37%-4.37%-9.01% 1.15B
-2.14%+7.11%+127.22%+74.14% 885M
-0.35%+1.42%-19.11%-55.81% 597M
-0.11%-1.57%+100.09%+156.71% 435M
-0.42%-1.10%-15.71%-10.33% 426M
+0.56%+4.07%+358.97%+878.14% 238M
Average -1.25%-0.54%+60.35%+132.20% 1.61B
Weighted average by Cap. -1.15%+0.46%+29.19%+31.87%

Financials

2024 2025
Net sales 45.85B 291M 256M 242M 220M 413M 27.95B 415M 2.88B 1.12B 14.28B 1.09B 1.07B 50.32B 319M 281M 266M 241M 453M 30.67B 456M 3.16B 1.23B 15.67B 1.2B 1.17B
Net income 172M 1.09M 961K 909K 824K 1.55M 105M 1.56M 10.8M 4.19M 53.57M 4.1M 4.01M 410M 2.6M 2.29M 2.17M 1.97M 3.69M 250M 3.71M 25.75M 9.99M 128M 9.78M 9.57M
Net Debt -7.48B -47.47M -41.77M -39.51M -35.84M -67.29M -4.56B -67.69M -470M -182M -2.33B -178M -174M -5.05B -32.04M -28.19M -26.66M -24.19M -45.41M -3.08B -45.68M -317M -123M -1.57B -120M -118M
Logo DVx Inc.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
Employees
334
  1. Stock Market
  2. Stocks
  3. 3079 Stock